Lawsuit Alleges Securities Fraud Against Replimune Group, Inc. (REPL)

Investors in Replimune Group, Inc. (REPL) have been reminded of the upcoming deadline to participate in a securities fraud class action lawsuit. Levi & Korsinsky, a prominent law firm in New York City, is representing investors in seeking compensation for potential financial losses due to alleged fraudulent activities by REPL. The deadline for investors to join the class action lawsuit is September 22, 2025.

The lawsuit alleges that REPL made misleading statements and failed to disclose important information to investors that could have impacted the company’s stock price. These alleged actions include misrepresenting the success of REPL’s clinical trials and the prospects for its cancer treatment products. As a result, investors may have suffered financial losses when the truth about REPL’s performance was revealed.

Investors who purchased REPL stock between April 23, 2020, and July 16, 2021, are encouraged to participate in the class action lawsuit. By joining the lawsuit, investors can potentially recover some of their losses incurred as a result of the alleged securities fraud committed by REPL. Levi & Korsinsky are committed to helping investors seek justice and hold companies accountable for engaging in fraudulent behavior.

If you believe that you may have been affected by the alleged securities fraud perpetrated by Replimune Group, Inc., you should consider joining the class action lawsuit before the September 22, 2025 deadline. By participating in the lawsuit, investors can pursue financial compensation for any losses suffered as a result of the misleading statements and omissions made by REPL. Levi & Korsinsky have a strong track record of success in representing investors in securities fraud cases and are dedicated to fighting for the rights of those who have been harmed by deceptive corporate practices.

In conclusion, investors in Replimune Group, Inc. (REPL) have until September 22, 2025, to join the securities fraud class action lawsuit filed against the company. If you purchased REPL stock between April 23, 2020, and July 16, 2021, and believe that you have suffered financial losses as a result of the company’s alleged fraudulent activities, you should consider participating in the lawsuit. Levi & Korsinsky are ready to assist investors in seeking justice and holding Replimune Group, Inc. accountable for any securities fraud committed.